2025 results about "Disodium hydrogen phosphate" patented technology

The invention discloses a high-efficiency graphene/silver phosphate composite visible light photocatalyst and a preparation method thereof, belonging to the technical field of composite materials and environmental management photocatalysis. The preparation method comprises the following steps: dissolving graphene oxide in water, and carrying out ultrasonic treatment to obtain a graphene oxide dispersed liquid; dissolving silver nitrate in deionized water, gradually and dropwisely adding into the graphene oxide dispersed liquid while stirring to obtain a mixed solution, uniformly stirring, and aging; dropwisely adding a prepared disodium hydrogen phosphate or sodium dihydrogen phosphate solution into the graphene oxide-silver nitrate mixed solution, continuing stirring, transferring into a hydrothermal reaction kettle, carrying out hydrothermal reaction, and cooling to room temperature; and washing the reaction product, and carrying out vacuum drying to obtain the visible light photocatalyst. The invention has the advantages of wide material sources and simple preparation process; and the obtained composite material has the advantages of controllable structure and regular pattern, and has high-efficiency degradation effect on organic dyes rhodamine B and methylene blue with certain concentration under the visible light irradiation.

Colonic evacuation, treatment of small bowel bacterial overgrowth or irritable bowel syndrome or treating acute or chronic bacterial bowel infection comprises administering an osmotic colonic evacuant in solid form, preferably a mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate or a sulfate based laxative comprising a picosulfate, together with a diluent.

The invention relates to a phase transition temperature adjusting cup, which comprises a cup body outer casing, a cup body inner casing and a top cover, and the composite phase transition material is filled between the inner casing and the outer casing. The composite phase transition material comprises phase transition material, a nucleating agent, heat conduction filling material and a thickening agent. The phase transition material is selected from one or more of sodium acetate trihydrate, sodium thiosulfate pentahydrate, twelve disodium hydrogen phosphate, sodium sulfate decahydrate and decahydrate. <{EN4}>The nucleating agent is selected from one or more of borax, sodium phosphate dibasic anhydrous, diatomaceous earth, silica, sodium silicate, eight water strontium hydroxide, hexahydrate chloride strontium. <{EN5}>The heat conduction filling material is selected from one or more of graphite, carbon nanotube, expanded graphite, carbon fiber, graphene, three-dimensional graphite foam, silicon carbide, copper powder. <{EN6}>The thickening agent is selected from one of polyacrylic acid emulsion or carboxymethylcellulose sodium. <{EN7}>Compared with existing temperature adjusting cups, the phase transition temperature adjusting cup of the present invention has the advantages of rapid cooling, simple structure convenient operation, 3-4 hours of comfort temperature zone, and not being restricted from external environment.

Colonic evacuation, treatment of small bowel bacterial overgrowth or irritable bowel syndrome or treating acute or chronic bacterial bowel infection comprises administering an osmotic colonic evacuant in solid form, preferably a mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate or a sulfate based laxative comprising a picosulfate, together with a diluent.

The invention discloses an alcohol-free fountain solution condensate. The process for preparing the alcohol-free fountain solution condensate comprises the following steps: proportionally weighing fatty alcohol-polyoxyethylene ether, coco-glucoside, Arabic gum, citric acid, sulfonylation dextrosamine, gluconic acid sodium salt, phosphoric acid and disodium hydrogen phosphate; dissolving the solid materials in water into solution, and diluting liquid materials in water; respectively putting the materials into a reaction kettle; and stirring for 30 to 45 minutes to obtain the alcohol-free fountain solution condensate. The alcohol-free fountain solution condensate does not contain alcohol or isopropanol, and can be used after being diluted by water into 2-3 percent solution. Fountain solution prepared from the alcohol-free fountain solution condensate not only ensures that the printing has high definition, vivid effect and wide application, but also has no harm to human body and no pollution to the environment. Compared with market fountain solution which consumes large amount of alcohol or isopropanol or alcohol-reduced fountain solution, the alcohol-free fountain solution condensate greatly reduces the cost.

The invention relates to a compound microbial agent which comprises compound bacteria for decomposing kitchen wastes and auxiliary materials for solid fermentation, wherein the compound bacteria comprise 10-15 parts of cellulose degradation bacteria, 15-30 parts of starch degradation bacteria, 15-20 parts of protein degradation bacteria, 15-20 parts of grease degradation bacteria, 10-15 parts of bacillus subtilis and 5-15 parts of pseudomonas aeruginosa; the auxiliary materials comprise 50-60 kg of wheat bran, 15-20 kg of bean pulp, 0.4-0.6 kg of magnesium sulfate, 0.4-0.6 kg of potassium dihydrogen phosphate, 0.1-0.2 kg of disodium hydrogen phosphate and 8-10 kg of glucose. The inoculation amount of the compound bacteria in the auxiliary materials is 0.8%-1%, and the compound bacteria is subjected to solid fermentation to obtain the compound microbial agent. The compound microbial agent has a good decomposing effect on greases, proteins and fiber substances and can be tolerant to salt with a certain concentration; optimally, the degradation rate can reach more than 90%.

The invention provides a new liquid aqueous drug preparation of an anti-TNF (tumor necrosis factor)-alpha human monoclonal antibody for strengthening the stability, wherein antibody solution is stabilized and osmotic pressure is regulated by sorbitol; disodium hydrogen phosphate/citric acid monohydrate or sodium acetate/acetic acid is taken as a buffer agent, and preferably, the disodium hydrogen phosphate/citric acid monohydrate is taken as the buffer agent; and tween-20 is taken as a surfactant, so that antibody preparation is stable, and long in retention time, meanwhile, preparation components are simplified, and the preparation is prepared simply and conveniently.

The combined treatment process of high concentration ammonia nitrogen waste water belongs to the field of waste water treating technology. The combined treatment process of high concentration ammonia nitrogen waste water features the combination of blow-off method, MAP method and nitrosation-anaerobic ammoxidation biological method. The treating process of the present invention includes the steps of: adding lime into the waste water in a regulating tank to reach pH of 11-12; blow-off and aerating in a blow-off tank, with the blow-off tail gas entering to an absorbing tank and the blow-off water entering to a MAP reaction tank; treating the blow-off effluent in the MAP reaction tank with thrown disodium hydrogen phosphate and magnesia to produce magnesium ammonium phosphate precipitate exhausted; and the final nitrosation-anaerobic ammoxidation biological treatment. The process has low power consumption and other advantages.

The present invention provides a freeze-dried medicine composition containing methylprednisolone sodium succinate and its preparation method. Said medicine composition includes 1-3000 mg of methylprednisolone sodium succinate as main component and auxiliary component including 1-1000 mg of sodium hydrogen carbonate or other alkaline medicinal auxiliary material 1-500 mg of lactose or other stabilizing agent. 1-50 mg of sodium dihydrogen phosphate or acid component of other pH buffering agent, 1-500 mg of disodium hydrogen phosphate or alkaline component of other pH buffering agent and 1-50 ml of injection water.

Discussed herein are pharmaceutical compositions containing Ibrutinib and processes for preparing them. The compositions may be utilized in the treatment of a variety of conditions including, without limitation, B-cell proliferative disorders such as non-Hodgkin lymphoma (diffuse large B cell lymphoma, follicular lymphoma, mantle cell lymphoma or burkitt lymphoma), Waldenstrom macroglobulinemia, plasma cell myeloma, chronic lymphocytic leukemia, lymphoma, or leukemia. These compositions are designed for oral ingestion. The compositions are contained within a capsule such as a standard or sprinkle or in a liquid formulation such as a suspension. In one embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, and magnesium stearate. In another embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, carboxymethylcellulose sodium, hydroxypropylmethylcellulose, citric acid monohydrate, disodium hydrogen phosphate, sucralose, sodium methyl parahydroxybenzoate, sodium ethyl parahydroxybenzoate, concentrated hydrochloric acid, sodium hydroxide, and water.

The present invention discloses a preparing method of the calcium phosphate cement/chitosan-gelatin composite scaffold, the process is as follows: mixing the alpha- tricalcium phosphate, monohydrate calcium biphosphate, hydroxyapatite and calcium carbonate according to the mass ration and rubbing, then obtaining the calcium carbonate cement solid powder; mixing the disodium hydrogen phosphate solution and the cement solid powder in the mass ratio and stirring to a mash, then filling into a mould, vacuum solidifying and mold releasing, after that, solidifying again and obtaining the calcium phosphate cement scaffold; subsequently, dissolving the chitosan and the gelatin into the acetic acid water solution, configuring the chitosan-gelatin solution and adding the glutaraldehyde water solution; putting the calcium phosphate cement scaffold into the chitosan-gelatin solution, in vacuum condition, filling chitosan-gelatin solution into the calcium phosphate cement scaffold, after that cooling and drying, obtaining the calcium phosphate cement/chitosan-gelatin composite scaffold. The prepared calcium phosphate cement/chitosan-gelatin composite scaffold has a perfect mechanical property and biological property.

The invention discloses a baicalin metal complex of which the molecular formula is (C21H17O11) xM (H2O) y, wherein M in the formula is Cu (II), x is 1 and y is 2; or M is Fe (III), x is 2 and y is 0; or M is La (III) or Y (III), x is 3 and y is 0. The preparation method comprises the following steps: adding aqueous alkali into baicalin until the baicalin and alkali (sodium bicarbonate, potassium bicarbonate, sodium formate, potassium formate, sodium acetate, potassium acetate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium phosphate or potassium phosphate) are just completely reacted, then adding metal salt (copper salt, ferric salt, lanthanum salt or yttrium salt) for reaction to obtain the baicalin metal complex. The baicalin metal complex has obviously stronger antibacterial and antitumor activities than the baicalin, can be used for preparing antibacterial drugs and antitumor drugs, and has good development and application prospects. In the preparation method, an organic solvent is not used, a strong basic condition is not adopted, and the method is simple and feasible, is green and environment-friendly and has the advantages of low cost, high product purity and high yield.

The present invention provides a deodorization sterilization foam liquid used in washroom which belongs to chemical technical field, and is used for solving problems of large water consumption, poor effects on deodorization and killing venomousness germina. The foam liquid is composed of components by weight part as follows: 12.0-17.5 parts anionic surfactant, 3.5-8.0 parts nonionic surfactant, 3.3-7.5 parts defoamer, 1.2-4.5 parts buffer, 0.8-2.0 parts perfume; anionic surfactant is one or more of alkyl sodium sulfonate, alpha-olefin sulfonates, sodium dodecyl sulfate, polyoxyethylene fatty alcohol sodium sulfate, nonionic surfactant is one of fatty acid alkanolamide and amine oxide, defoamer is one of isopropanol and ethanol, buffer is one of citric acid and disodium hydrogen phosphate. Or fungicidal preservative, cationic alkyl glycoside are added. The foam liquid has reasonable prescription, gathers in integral whole of sterilization, deodorization, clean, contaminant separation and froth, and is suitable for various washroom, especially for various environmental protection water saving type washroom.

The invention discloses boilproof alumen-free sheet jellies and a processing method thereof. The boilproof alumen-free sheet jellies comprise the raw materials of starch, oxidized starch, sodium alginate, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium carbonate, salt and water. The boilproof alumen-free sheet jellies have the advantages that: the oxidized modified starch is applied to the process for preparing the sheet jellies for the first time; the paste liquid of the oxidized starch is transparent; the paste strip is short; and gelatinous property and film-forming property are high. The oxidized starch has a coordinated compatible and complementary action with the sodium alginate, the sodium dihydrogen phosphate, the disodium hydrogen phosphate, the sodium carbonate and the salt to form a good network structure. Therefore, the prepared sheet jellies have the characteristics of good mouthfeel, boiling resistance, no turbid soup, no broken strips and high transparency. The used oxidized starch has the advantages of simple preparation, eating safety and low cost.

The invention relates to a lansoprazole crystalline compound. An X-ray powder diffraction pattern represented by a diffraction angle of 2 theta +/- 0.2 DEG displays feature diffraction peaks at the positions of 5.8 DEG, 7.5 DEG, 9.1 DEG, 11.8 DEG, 12.1 DEG, 12.8 DEG, 13.3 DEG, 15.6 DEG, 16.7 DEG, 18.3 DEG, 20.4 DEG, 25.7 DEG, 26.8 DEG and 31.5 DEG. The invention also relates to a lansoprazole enteric capsule containing the lansoprazole crystalline compound. The lansoprazole enteric capsule comprises 20 to 60 parts of l crystalline compound, 90 to 140 parts of microcrystalline cellulose, 1.5 to 3.5 parts of disodium hydrogen phosphate, 2 to 5 parts of anhydrous sodium sulphite, 1 to 10 parts of crospovidone, 0.8 to 4.2 parts of lauryl sodium sulfate, 2 to 8 parts of povidone K30 and 1 to 3 parts of magnesium stearate.

The invention relates to a preparation method of a ZnFe2O4/ Ag3PO4 composite photocatalyst, belonging to the technical field of environmental material preparation. An ion exchange technique is adopted for the invention, and the preparation method comprises the steps of firstly, feeding FeCl3.6H2O solid and ZnCl2 solid into ethylene glycol, evenly stirring, then feeding sodium acetate (NaAC) and polyethylene glycol (PEG) into the mixture, continuously mixing, and carrying out a reaction to obtain ZnFe2O4 nanospheres; after that, feeding the ZnFe2O4 nanospheres into deionized water, rapidly stirring, dropwise adding a disodium hydrogen phosphate solution, carrying out a reaction, then dropwise adding a silver nitrate solution, stirring until reactants have a full reaction, washing the product, and then carrying out vacuum drying on the washed product to obtain the ZnFe2O4/Ag3PO4 composite photocatalyst. A composite visible light photocatalyst system is established; a heterogeneous structure system is established, so that the activity and the stability of silver phosphate can be improved; furthermore, the photocatalyst can be efficiently recovered by using the ZnFe2O4; the composite photocatalyst has a better degrading effect for the antibiotics in waste water.

The invention provides a biophysical method for removing the endopleura of a walnut. The walnut with the shell is soaked by tap water for 12 to 24 hours, the shell is removed, the kernel is taken out, pectinase with the activity being 30000 IU is dissolved into disodium hydrogen phosphate-citric acid buffer liquid with the pH being 3.2 to 3.8, and 3 percent to 5 percent of pectic enzyme liquid is prepared and is heated to 50 DEG C. The soaked walnut kernel is soaked in the pectic enzyme liquid and is placed into an ultrasonic generator with the power being 250W and the work frequency being 40KHZ, the enzymolysis and the ultrasonic treatment are carried out for 2.5 to 5 hours at the constant temperature being 50 DEG C, the walnut kernel is fished out and is sprayed and flushed by flowing water with the pressure being 7 to 10 MPa until the endopleura is completely removed, the walnut kernel with the advantages that the color and the luster are opacified, the kernel fruit is complete, the texture is flexible, the mouth feeling and the flavor are pure and sweet as those of the fresh walnut kernel can be obtained, and when the walnut kernel is in vacuum package and freezing storage, a fresh walnut kernel storage method is obtained. The biophysical method adopts the advanced biological enzyme technology to be combined with the ultrasonic physical technology and has the obvious characteristics that the operation is simple, the processing condition is mild, no chemical pollution exists, the kernel and the nutrition are kept complete, and the sensory quality is good.

The invention discloses a synthesizing method of a playgouskite-loaded silver orthophosphate photochemical catalyst, which belongs to the technical filed of sewage treatment in environmental protection. The method comprises the flowing steps of mixing 20 mmol/L of silver nitrate solution and 20 mmol/L of disodium hydrogen phosphate solution at a rotation speed of 350-400 rpm, and continuously mixing for 3-4 h so as to obtain silver nitrate colloid; and adding 5-8 g of attapulgite into 50-60 ml of water, dispersing under ultrasonic waves for 60-70 min, adding into the silver nitrate colloid, stirring for 6-8 h, aging for 24 h, centrifuging, collecting solid, and drying at temperature of 105 DEG C so as to obtain the catalyst. According to the method, the nano rod-shape large outer surface of the attapulgite is utilized, silver nitrate is loaded on the outer surface so that the light can be received advantageously , the generated silver nitrate colloid is easily attached to the huge outer surface of the attapulgite and can be distributed uniformly, further the outer surface of the attapulgite can be utilized effectively, and the silver nitrate still can play a nano effect and can be speared from the water.

The invention discloses a method for extracting hesperidin from tangerine peel. The method comprises: mixing tangerine peel with a solid-phase alkali reagent, wherein the tangerine peel is tangerine peel powder which is ground to have a powder particle size analysis result D90 between 10 and 200 mu m; adding water, stirring, centrifuging and taking supernatant; adding acid to regulate pH between 2.0 and 6.0; standing and then filtering the obtained product; drying a filter cake; and obtaining hesperidin. The solid-phase alkali reagent is one or arbitrary mixture of more than two of sodium hydroxide, aluminum hydroxide, calcium hydroxide, potassium hydroxide, sodium bicarbonate, potassium bicarbonate, sodium carbonate, potassium carbonate, calcium carbonate, sodium silicate, disodium hydrogen phosphate or dipotassium hydrogen phosphate. By adopting a mechanochemical technique to extract and separate the hesperidin, the method has the advantages of high extraction rate, high product purity, simple process, environment-friendly property, low cost and short production cycle, and is an extraction-separation route with broad industrialization prospects.

The invention provides a graphene oxide/silver phosphate composite visible light catalyst and a preparation method of the graphene oxide/silver phosphate composite visible light catalyst, belonging to the technical field of nano-composite material and photocatalysis. The preparation method comprises the following steps of: dissolving graphene oxide in water, and ultrasonically treating to obtain graphene oxide dispersing liquid; adding silver acetate into the graphene oxide dispersing liquid, and evenly stirring, to obtain mixed solution; slowly dropping prepared disodium hydrogen phosphate or sodium dihydrogen phosphate solution into the mixed solution of the graphene oxide and the silver acetate to continuously stir for a while; and repeatedly washing products obtained by reaction with deionized water and absolute ethyl alcohol, and carrying out vacuum drying to obtain the graphene oxide/silver phosphate nano-composite visible light catalyst. The invention has the advantages that the invention is wide in raw material source, and simple in preparation process, the obtained composite material is better in structure and feature, and the prepared nano-composite light catalyst is high-efficiency in degradation effect to the organic dyestuff rhodamine B and the methylene blue under the irradiation of visible light due to the structural advantage.